Kyung Su Kim1, Suk-Jin Seo1, Jaegi Lee1, Jin-Yong Seok2, Joo Wan Hong2, Jin-Beom Chung2, Eunji Kim1, Noorie Choi1, Keun-Yong Eom1,2, Jae-Sung Kim1,2, In Ah Kim3,4. 1. Departments of Radiation Oncology, Seoul National University College of Medicine, Seoul, Republic of Korea. 2. Department of Radiation Oncology, Seoul National University Bundang Hospital, 166 Gumiro, 13620, Seongnamsi, Kyeonggido, Republic of Korea. 3. Departments of Radiation Oncology, Seoul National University College of Medicine, Seoul, Republic of Korea. inah228@snu.ac.kr. 4. Department of Radiation Oncology, Seoul National University Bundang Hospital, 166 Gumiro, 13620, Seongnamsi, Kyeonggido, Republic of Korea. inah228@snu.ac.kr.
Abstract
PURPOSE: Hippocampal-sparing whole brain radiotherapy (HS-WBRT) aims to preserve neurocognitive functions in patients undergoing brain radiotherapy (RT). Volumetric modulated arc therapy (VMAT) involves intensity-modulated RT using a coplanar arc. An inclined head position might improve dose distribution during HS-WBRT using VMAT. MATERIALS AND METHODS: This study analyzed 8 patients receiving brain RT with inclined head positioning. A comparable set of CT images simulating a non-inclined head position was obtained by rotating the original CT set. HS-WBRT plans of coplanar VMAT for each CT set were generated with a prescribed dose of 30 Gy in 10 fractions. Maximum dose to the hippocampi was limited to 16 Gy; to the optic nerve, optic chiasm, and eyeballs this was confined to less than 37.5 Gy; for the lenses to 8 Gy. Dosimetric parameters of the two different plans of 8 patients were compared with paired t-test. RESULTS: Mean inclined head angle was 11.09 ± 0.73°. The homogeneity (HI) and conformity (CI) indexes demonstrated improved results, with an average 8.4 ± 10.0 % (p = 0.041) and 5.3 ± 3.9 % (p = 0.005) reduction, respectively, in the inclined vs. non-inclined position. The inclined head position had lower hippocampi Dmin (10.45 ± 0.36 Gy), Dmax (13.70 ± 0.25 Gy), and Dmean (12.01 ± 0.38 Gy) values vs. the non-inclined head position (Dmin = 12.07 ± 1.07 Gy; Dmax = 15.70 ± 1.25 Gy; Dmean = 13.91 ± 1.01 Gy), with 12.8 ± 8.9 % (p = 0.007), 12.2 ± 6.8 % (p = 0.003), and 13.2 ± 7.2 % (p = 0.002) reductions, respectively. Mean Dmax for the lenses was 6.34 ± 0.72 Gy and 7.60 ± 0.46 Gy, respectively, with a 16.3 ± 10.8 % reduction in the inclined position (p = 0.004). Dmax for the optic nerve and Dmean for the eyeballs also decreased by 7.0 ± 5.9 % (p = 0.015) and 8.4 ± 7.2 % (p = 0.015), respectively. CONCLUSION: Inclining the head position to approximately 11° during HS-WBRT using VMAT improved dose distribution in the planning target volume and allowed lower doses to the hippocampi and optic apparatus.
PURPOSE: Hippocampal-sparing whole brain radiotherapy (HS-WBRT) aims to preserve neurocognitive functions in patients undergoing brain radiotherapy (RT). Volumetric modulated arc therapy (VMAT) involves intensity-modulated RT using a coplanar arc. An inclined head position might improve dose distribution during HS-WBRT using VMAT. MATERIALS AND METHODS: This study analyzed 8 patients receiving brain RT with inclined head positioning. A comparable set of CT images simulating a non-inclined head position was obtained by rotating the original CT set. HS-WBRT plans of coplanar VMAT for each CT set were generated with a prescribed dose of 30 Gy in 10 fractions. Maximum dose to the hippocampi was limited to 16 Gy; to the optic nerve, optic chiasm, and eyeballs this was confined to less than 37.5 Gy; for the lenses to 8 Gy. Dosimetric parameters of the two different plans of 8 patients were compared with paired t-test. RESULTS: Mean inclined head angle was 11.09 ± 0.73°. The homogeneity (HI) and conformity (CI) indexes demonstrated improved results, with an average 8.4 ± 10.0 % (p = 0.041) and 5.3 ± 3.9 % (p = 0.005) reduction, respectively, in the inclined vs. non-inclined position. The inclined head position had lower hippocampi Dmin (10.45 ± 0.36 Gy), Dmax (13.70 ± 0.25 Gy), and Dmean (12.01 ± 0.38 Gy) values vs. the non-inclined head position (Dmin = 12.07 ± 1.07 Gy; Dmax = 15.70 ± 1.25 Gy; Dmean = 13.91 ± 1.01 Gy), with 12.8 ± 8.9 % (p = 0.007), 12.2 ± 6.8 % (p = 0.003), and 13.2 ± 7.2 % (p = 0.002) reductions, respectively. Mean Dmax for the lenses was 6.34 ± 0.72 Gy and 7.60 ± 0.46 Gy, respectively, with a 16.3 ± 10.8 % reduction in the inclined position (p = 0.004). Dmax for the optic nerve and Dmean for the eyeballs also decreased by 7.0 ± 5.9 % (p = 0.015) and 8.4 ± 7.2 % (p = 0.015), respectively. CONCLUSION: Inclining the head position to approximately 11° during HS-WBRT using VMAT improved dose distribution in the planning target volume and allowed lower doses to the hippocampi and optic apparatus.
Entities:
Keywords:
Cognitive function; Intensity-modulated radiotherapy; Metastases; Organs at risk; Survival
Authors: James C Marsh; Rohit H Godbole; Arnold M Herskovic; Benjamin T Gielda; Julius V Turian Journal: Int J Radiat Oncol Biol Phys Date: 2010-05-14 Impact factor: 7.038
Authors: E Shaw; C Scott; L Souhami; R Dinapoli; R Kline; J Loeffler; N Farnan Journal: Int J Radiat Oncol Biol Phys Date: 2000-05-01 Impact factor: 7.038
Authors: Vinai Gondi; Stephanie L Pugh; Wolfgang A Tome; Chip Caine; Ben Corn; Andrew Kanner; Howard Rowley; Vijayananda Kundapur; Albert DeNittis; Jeffrey N Greenspoon; Andre A Konski; Glenn S Bauman; Sunjay Shah; Wenyin Shi; Merideth Wendland; Lisa Kachnic; Minesh P Mehta Journal: J Clin Oncol Date: 2014-10-27 Impact factor: 44.544
Authors: Fred Hsu; Hannah Carolan; Alan Nichol; Fred Cao; Nimet Nuraney; Richard Lee; Ermias Gete; Frances Wong; Moira Schmuland; Manraj Heran; Karl Otto Journal: Int J Radiat Oncol Biol Phys Date: 2009-07-20 Impact factor: 7.038
Authors: James C Marsh; G Ellis Ziel; Aidnag Z Diaz; Julie A Wendt; Rohit Gobole; Julius V Turian Journal: J Med Imaging Radiat Oncol Date: 2013-04-07 Impact factor: 1.735
Authors: Tomas Kazda; Radim Jancalek; Petr Pospisil; Ondrej Sevela; Tomas Prochazka; Miroslav Vrzal; Petr Burkon; Marek Slavik; Ludmila Hynkova; Pavel Slampa; Nadia N Laack Journal: Radiat Oncol Date: 2014-06-16 Impact factor: 3.481
Authors: P Mehta; S Janssen; F B Fahlbusch; S M Schmid; J Gebauer; F Cremers; C Ziemann; M Tartz; D Rades Journal: BMC Cancer Date: 2020-06-30 Impact factor: 4.430